Pharmaceutical

Filter

Current filters:

None

Popular Filters

101 to 125 of 6944 results

Smarter research spending would boost French innovation, says OECD

27-06-2014

Encouraging private-sector innovation, making public research institutions more accountable and channelling…

FinancialFrancePharmaceuticalPoliticsResearch

UK’s NICE draft guidance backs Novartis’ Glivec for GISTs

UK’s NICE draft guidance backs Novartis’ Glivec for GISTs

27-06-2014

UK health care watchdog the National Institute for Health and Care Excellence (NICE) has issued new draft…

GlivecNovartisOncologyPharmaceuticalPricingRegulationUK

Eisai files first marketing application for lenvatinib in Japan

Eisai files first marketing application for lenvatinib in Japan

26-06-2014

Japanese pharma major Eisai said today that it has submitted its first marketing authorization application…

EisaiJapanlenvatinibOncologyPharmaceuticalRegulation

FDA Breakthrough status for Boehringer’s investigational Pradaxa antidote

FDA Breakthrough status for Boehringer’s investigational Pradaxa antidote

26-06-2014

The US Food and Drug Administration has granted Breakthrough Therapy designation to idarucizumab, an…

Boehringer IngelheimCardio-vascularidarucizumabPharmaceuticalPradaxaRegulationResearchUSA

Auxilium to merge with Canada’s QLT

Auxilium to merge with Canada’s QLT

26-06-2014

US drugmaker Auxilium Pharmaceuticals and Canadian biotech firm QLT Inc have entered into a definitive…

Auxilium PharmaceuticalsMergers & AcquisitionsPharmaceuticalQLT

US psychiatrists’ views on prescribing Otsuka/Lundbeck’s brexpiprazole

26-06-2014

Surveyed US psychiatrists are receptive to novel adjunctive therapies to antidepressants for treatment-resistant…

brexpiprazoleBrintellixLundbeckMarkets & MarketingNeurologicalOtsukaPharmaceuticalUSA

Teijin inks exclusive deal with Sigma-Tau for EZN-2279 in Japan

Teijin inks exclusive deal with Sigma-Tau for EZN-2279 in Japan

26-06-2014

Japanese firm Teijin has entered into an agreement with the UK subsidiary of privately-owned Italian…

EZN-2279ImmunologicalsJapanLicensingPharmaceuticalSigma-TauTeijin

Brintellix meets primary efficacy end-point in depression study

Brintellix meets primary efficacy end-point in depression study

26-06-2014

Danish CNS drug specialist Lundbeck has announced results of the SOLUTION trial conducted in Asian patients…

BrintellixDenmarkLundbeckNeurologicalPharmaceuticalResearch

BioAlliance Pharma signs deal with EMS for Sitavig in Brazil

BioAlliance Pharma signs deal with EMS for Sitavig in Brazil

26-06-2014

French oncology specialist BioAlliance Pharma SA has announced a license agreement for Sitavig (acyclovir…

Antibiotics and Infectious diseasesBioAlliance PharmaBrazilLicensingPharmaceuticalSitavig

AbbVie justifies its position regarding Shire offer

AbbVie justifies its position regarding Shire offer

26-06-2014

US drugmaker AbbVie has set out its ‘strategic rationale’ for its proposal to buy Ireland headquartered…

AbbVieFinancialPharmaceuticalShire PharmaceuticalsUSA

Record year for commercial contract clinical research in England

Record year for commercial contract clinical research in England

26-06-2014

The National Institute for Health Research (NIHR) Clinical Research Network has today released record…

PharmaceuticalResearchUK

Negative view from FDA advisory for AstraZeneca’s olaparib

Negative view from FDA advisory for AstraZeneca’s olaparib

26-06-2014

There was disappointment for Anglo-Swedish pharma major AstraZeneca yesterday when a US Food and Drug…

AstraZenecaLynparzaolaparibOncologyPharmaceuticalRegulationUSA

Bristol-Myers Ph III nivolumab trial stopped early on good results

Bristol-Myers Ph III nivolumab trial stopped early on good results

25-06-2014

Shares of US pharma major Bristol-Myers Squibb rose 2.6% to $49.55 in post-market trading on June 25,…

Bristol-Myers SquibbnivolumabOncologyPharmaceuticalResearch

US orphan status for Insys Therapeutics’ cannabidiol for rare form of epilepsy

US orphan status for Insys Therapeutics’ cannabidiol for rare form of epilepsy

25-06-2014

US specialty pharma firm Insys Therapeutics says that the US Food and Drug Administration has granted…

cannabidiolInsys TherapeuticsNeurologicalPharmaceuticalRare diseasesRegulationUSA

FDA review of CV risks for diabetics taking olmesartan not conclusive

FDA review of CV risks for diabetics taking olmesartan not conclusive

25-06-2014

The US Food and Drug Administration has completed its safety review and has found no clear evidence of…

BenicarCardio-vascularDaiichi SankyoDiabetesolmesartanPharmaceuticalRegulationUSA

Outcome report on first European collaboration between regulators and HTA organizations

Outcome report on first European collaboration between regulators and HTA organizations

25-06-2014

The report of an initiative undertaken jointly by the European Medicines Agency and the European network…

EuropePharmaceuticalRegulation

Pharma industry is expected to exceed $1 trillion by 2020

25-06-2014

Record breaking new drug approvals, a hefty product pipeline and dramatically improved R&D productivity…

Pharmaceutical

Rilutek patent expiry to cause negative growth in ALS treatment market by 2018

Rilutek patent expiry to cause negative growth in ALS treatment market by 2018

25-06-2014

The amyotrophic lateral sclerosis (ALS) treatment market value will decline from $64 million in 2013…

EuropeJapanMarkets & MarketingNeurologicalPatentsPharmaceuticalRilutekSanofiUSA

Ferring and Roche collaborate to develop personalized infertility treatment

Ferring and Roche collaborate to develop personalized infertility treatment

25-06-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals and Swiss drug major Roche have entered…

Ferring PharmaceuticalsPharmaceuticalReproductiveResearchRocheWomen's Health

UK’s NICE approves Janssen’s Invokana for type 2 diabetes

UK’s NICE approves Janssen’s Invokana for type 2 diabetes

25-06-2014

The UK’s National Institute for Health and Care Excellence (NICE) has issued new final guidance recommending…

DiabetesInvokanaJanssenPharmaceuticalRegulationUK

New report calls on governments to implement national policies on hepatitis C

New report calls on governments to implement national policies on hepatitis C

25-06-2014

A report published by The Economist Intelligence Unit (EIU) has revealed that many countries around the…

Anti-viralsGlobalHealthcareJanssenPharmaceutical

Shire gets positive ruling on Vyvanse patents from US district court

25-06-2014

Ireland-headquartered drugmaker Shire, which is defending itself from a $46 billion unsolicited bid from…

ActavisAmneal PharmaLegalMylanNeurologicalPatentsPharmaceuticalRoxaneSandozShireUSAVyvanse

101 to 125 of 6944 results

Back to top